1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine has been researched along with adenosine in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (25.00) | 18.7374 |
| 1990's | 16 (66.67) | 18.2507 |
| 2000's | 2 (8.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baulieu, EE; el-Etr, M; Erlanger, BF; Lombes, M | 1 |
| DeLuca, B; Jovetich, M; Middlemiss, PJ; Rathbone, MP | 1 |
| Chabardès, D; Montégut, M; Siaume-Perez, S; Zhou, Y | 1 |
| Braunwalder, A; Cash, WD; Francis, J; Ghai, G; Psychoyos, S; Stone, GA; Williams, M | 1 |
| Burnstock, G; Hoyle, CH | 1 |
| Baines, AD; Ramos-Salazar, A | 1 |
| Braunwalder, A; Ferkany, JW; Jarvis, MF; Sills, MA; Williams, M | 1 |
| Braunwalder, A; Erickson, TJ; Williams, M | 1 |
| Kenakin, TP; Pike, NB | 1 |
| Borchard, U; Felsch, A; Stöcker, K | 1 |
| Castillo-Meléndez, M; Jarrott, B; Krstew, E; Lawrence, AJ | 1 |
| Haynes, JM; Pennefather, JN | 1 |
| Aley, KO; Green, PG; Levine, JD | 1 |
| Aley, KO; Levine, JD | 1 |
| Judd, AM; Krzymowski, DK; Kurth, E; Ritchie, PK; Rossiter, TB; Spangelo, BL | 1 |
| Florio, C; Rosati, AM; Traversa, U; Vertua, R | 1 |
| Jarrott, B; Krstew, E; Lawrence, AJ | 2 |
| Kim, YH; Song, DK; Suh, HW | 1 |
| Deguchi, H; Gabazza, EC; Suzuki, K; Takeya, H; Urano, H; Zhou, H | 1 |
| Kaplan, GB; Weisberg, SP | 1 |
| Broussas, M; Cornillet-Lefèbvre, P; Nguyen, P; Potron, G | 1 |
| Chandilawa, R; Dagar, S; Gao, XP; Hong, D; Rubinstein, I | 1 |
| Alhaj, M; Bozarov, A; Christofi, FL; Cooke, HJ; Grants, I; Hassanain, HH; Ren, T; Wang, YZ; Wunderlich, J; Yu, JG | 1 |
24 other study(ies) available for 1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine and adenosine
| Article | Year |
|---|---|
A monoclonal anti-idiotypic 'internal image' antibody that recognizes the A1 adenosine receptor potentiates the alpha 1-adrenergic activation of phospholipase C in primary cultures of mouse striatal astrocytes.
Topics: 2-Chloroadenosine; 5,8,11,14-Eicosatetraynoic Acid; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Astrocytes; Cells, Cultured; Corpus Striatum; Enzyme Activation; Female; Mice; Norepinephrine; Pregnancy; Quinacrine; Receptors, Adrenergic, alpha; Receptors, Purinergic; Type C Phospholipases; Xanthines | 1992 |
Extracellular guanosine increases astrocyte cAMP: inhibition by adenosine A2 antagonists.
Topics: Adenosine; Animals; Astrocytes; Brain; Cell Division; Cells, Cultured; Chick Embryo; Cyclic AMP; Guanosine; Purinergic Antagonists; Receptors, Purinergic; Second Messenger Systems; Theophylline; Xanthines | 1991 |
Two mechanisms of inhibition by prostaglandin E2 of hormone-dependent cell cAMP in the rat collecting tubule.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adenosine; Animals; Arginine Vasopressin; Colforsin; Cyclic AMP; Dinoprostone; Indomethacin; Isoproterenol; Kidney Tubules, Collecting; Male; Phenylisopropyladenosine; Rats; Rats, Inbred Strains; Signal Transduction; Xanthines | 1990 |
Biochemical characterization of the triazoloquinazoline, CGS 15943, a novel, non-xanthine adenosine antagonist.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Binding, Competitive; Brain; Guinea Pigs; Kinetics; Neurotransmitter Agents; Pyrazoles; Quinazolines; Rats; Receptors, Purinergic; Triazoles; Xanthines | 1987 |
PACPX--a substituted xanthine--antagonizes both the A1 and A2 subclasses of the P1-purinoceptor: antagonism of the A2 subclass is competitive but antagonism of the A1 subclass is not.
Topics: Adenosine; Animals; Binding, Competitive; Colon; Dipyridamole; Female; Guinea Pigs; In Vitro Techniques; Male; Muscle, Smooth; Myocardial Contraction; Norepinephrine; Receptors, Neurotransmitter; Receptors, Purinergic; Theophylline; Xanthines | 1985 |
Role of 5'-nucleotidase in adenosine-mediated renal vasoconstriction during hypoxia.
Topics: 5'-Nucleotidase; Adenine Nucleotides; Adenosine; Adenosine Deaminase; Animals; Glomerular Filtration Rate; In Vitro Techniques; Kidney; Kidney Tubules; Male; Nucleotidases; Oxygen; Rats; Rats, Inbred Strains; Vascular Resistance; Vasoconstriction; Xanthines | 1986 |
Biochemical characterization of the antagonist actions of the xanthines, PACPX (1,3-dipropyl-8(2-amino-4-chloro)phenylxanthine) and 8-PT (8-phenyltheophylline) at adenosine A1 and A2 receptors in rat brain tissue.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Brain; In Vitro Techniques; Kinetics; Rats; Receptors, Purinergic; Theophylline; Xanthines | 1987 |
Evaluation of the binding of the A-1 selective adenosine radioligand, cyclopentyladenosine (CPA), to rat brain tissue.
Topics: Adenosine; Animals; Brain; Kinetics; Membranes; Phenylisopropyladenosine; Purine Nucleotides; Pyrazoles; Rats; Xanthines | 1986 |
An in vitro analysis of purine-mediated renal vasoconstriction in rat isolated kidney.
Topics: 2-Chloroadenosine; Adenosine; Animals; Colforsin; Male; Methoxamine; Phenylisopropyladenosine; Rats; Rats, Inbred Strains; Receptors, Purinergic; Renal Circulation; Theophylline; Vasoconstriction; Xanthines | 1987 |
Adenosine A1 and A2 receptor agonists alter cardiac functions and prostacyclin release in the isolated guinea-pig heart.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine; Animals; Antihypertensive Agents; Cardiac Pacing, Artificial; Cells, Cultured; Coronary Circulation; Dose-Response Relationship, Drug; Endothelium, Vascular; Epoprostenol; Guinea Pigs; Heart; Heart Rate; Male; Myocardium; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Quinazolines; Triazoles; Vasodilation; Ventricular Function, Left; Xanthines | 1994 |
Presynaptic adenosine A2a receptors on soma and central terminals of rat vagal afferent neurons.
Topics: Adenosine; Amino Acids; Animals; Antihypertensive Agents; Antineoplastic Agents; Autoradiography; Brain Stem; Electrophysiology; Ganglionectomy; Male; Microdialysis; Nerve Endings; Neurons, Afferent; Nodose Ganglion; Phenethylamines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Solitary Nucleus; Synapses; Vagus Nerve; Xanthines | 1994 |
A1- and A2-purinoceptors in the guinea-pig uterus.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Binding, Competitive; Cyclic AMP; Dose-Response Relationship, Drug; Endometrium; Female; Guinea Pigs; In Vitro Techniques; Myometrium; Phenethylamines; Phenylephrine; Phenylisopropyladenosine; Radioligand Assay; Receptors, Purinergic; Theobromine; Uterine Contraction; Xanthines | 1993 |
Opioid and adenosine peripheral antinociception are subject to tolerance and withdrawal.
Topics: Adenosine; Analgesics; Animals; Dinoprostone; Drug Tolerance; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Hyperalgesia; Male; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Nociceptors; Rats; Rats, Sprague-Dawley; Xanthines | 1995 |
Multiple receptors involved in peripheral alpha 2, mu, and A1 antinociception, tolerance, and withdrawal.
Topics: Adenosine; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Analgesics; Analgesics, Opioid; Animals; Clonidine; Dinoprostone; Drug Interactions; Drug Tolerance; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Hyperalgesia; Male; Models, Biological; Naloxone; Narcotic Antagonists; Oligonucleotides, Antisense; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Opioid, mu; Receptors, Purinergic P1; Second Messenger Systems; Substance Withdrawal Syndrome; Substance-Related Disorders; Xanthines; Yohimbine | 1997 |
Adenosine increases interleukin 6 release and decreases tumour necrosis factor release from rat adrenal zona glomerulosa cells, ovarian cells, anterior pituitary cells, and peritoneal macrophages.
Topics: Adenosine; Adrenocorticotropic Hormone; Animals; Antineoplastic Agents; Cells, Cultured; Female; Interleukin-6; Macrophages, Peritoneal; Ovary; Phenethylamines; Pituitary Gland, Anterior; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Xanthines; Zona Glomerulosa | 1997 |
Inhibitory and excitatory effects of adenosine antagonists on spontaneous locomotor activity in mice.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Antineoplastic Agents; Male; Mice; Motor Activity; Purinergic P1 Receptor Agonists; Purines; Sulfonamides; Theophylline; Xanthines | 1997 |
Complex interactions between nitric oxide and adenosine receptors in the rat isolated nodose ganglion.
Topics: Adenosine; Animals; Antineoplastic Agents; Diethylamines; Dose-Response Relationship, Drug; Drug Interactions; Electrophysiology; In Vitro Techniques; Male; Neurons, Afferent; Nitric Oxide; Nodose Ganglion; Norbornanes; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Vagus Nerve; Xanthines | 1997 |
Differential effects of adenosine receptor antagonists injected intrathecally on antinociception induced by morphine and beta-endorphin administered intracerebroventricularly in the mouse.
Topics: Adenosine; Analgesics; Animals; beta-Endorphin; Dose-Response Relationship, Drug; Injections, Intraventricular; Injections, Spinal; Male; Mice; Mice, Inbred ICR; Morphine; Phenethylamines; Purinergic P1 Receptor Antagonists; Reaction Time; Theobromine; Xanthines | 1997 |
Adenosine regulates tissue factor expression on endothelial cells.
Topics: Adenosine; Cardiovascular Agents; Cells, Cultured; Endothelium, Vascular; Hemostatics; Humans; Infant, Newborn; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Tetradecanoylphorbol Acetate; Thrombin; Thromboplastin; Tumor Necrosis Factor-alpha; Umbilical Veins; Xanthines | 1998 |
Autoradiographic visualisation of axonal transport of adenosine A1 receptors along the rat vagus nerve and characterisation of adenosine A1 receptor binding in the dorsal vagal complex of hypertensive and normotensive rats.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Autoradiography; Axonal Transport; Binding, Competitive; Hypertension; Male; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Purinergic P1; Reference Values; Solitary Nucleus; Vagus Nerve; Xanthines | 1998 |
Adenosine receptor antagonists inhibit the development of morphine sensitization in the C57BL/6 mouse.
Topics: Adenosine; Animals; Caffeine; Drug Combinations; Drug Resistance; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Morphine; Motor Activity; Narcotics; Purinergic P1 Receptor Antagonists; Xanthines | 1999 |
Inhibition of fMLP-triggered respiratory burst of human monocytes by adenosine: involvement of A3 adenosine receptor.
Topics: Adenosine; Bucladesine; Calcium; Carbazoles; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cytochalasin B; Enzyme Activation; Enzyme Inhibitors; Flow Cytometry; Humans; Indoles; Luminescent Measurements; Monocytes; N-Formylmethionine Leucyl-Phenylalanine; NADPH Oxidases; Oxygen Consumption; Pyrroles; Receptor, Adenosine A3; Receptors, Purinergic P1; Respiratory Burst; RNA, Messenger; Second Messenger Systems; Theobromine; Xanthines | 1999 |
Adenosine A(1) receptors mediate plasma exudation from the oral mucosa.
Topics: Adenosine; Animals; Bradykinin; Cricetinae; Dextrans; Exudates and Transudates; Fluorescein-5-isothiocyanate; Indomethacin; Male; Mesocricetus; Mouth Mucosa; NG-Nitroarginine Methyl Ester; Nitroglycerin; Phenethylamines; Phenylisopropyladenosine; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Theobromine; Xanthines | 2001 |
Activation of adenosine low-affinity A3 receptors inhibits the enteric short interplexus neural circuit triggered by histamine.
Topics: Adenosine; Animals; Chlorides; Cimetidine; Colon; Dihydropyridines; Dimaprit; Dose-Response Relationship, Drug; Enteric Nervous System; Gastrointestinal Motility; Guinea Pigs; Histamine; Histamine Agonists; Histamine H2 Antagonists; In Vitro Techniques; Intestinal Secretions; Male; Mecamylamine; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Neural Inhibition; Neurogenic Bowel; Neurokinin-1 Receptor Antagonists; Nicotinic Antagonists; Piperidines; Propane; Receptor, Adenosine A1; Receptor, Adenosine A3; Receptors, Histamine H2; Receptors, Neurokinin-1; Reflex; Theophylline; Xanthines | 2009 |